학술논문

Correction: Cost-effectiveness of apixaban compared to other anticoagulants in patients with atrial fibrillation in the real-world and trial settings.
Document Type
Correction Notice
Source
PLoS ONE. 3/31/2022, Vol. 17 Issue 3, p1-5. 5p.
Subject
*APIXABAN
*ATRIAL fibrillation
*ANTICOAGULANTS
*COST effectiveness
*ORAL medication
Language
ISSN
1932-6203